Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: Creatine deficiency syndromes are a newly described group of inborn errors of creatine synthesis (arginine:glycine amidinotransferase (AGAT) deficiency and guanidinoaceteate methyltransferase (GAMT) deficiency) and creatine transport (creatine transporter (CRTR) deficiency). The common clinical denominator of creatine deficiency syndromes is mental retardation and epilepsy, suggesting the main involvement of cerebral grey matter (grey matter disease). Patients with GAMT deficiency exhibit a more complex clinical phenotype with dystonic hyperkinetic movement disorder and epilepsy that in some cases is unresponsive to pharmacological treatment. The common biochemical denominator of creatine deficiency syndromes is cerebral creatine deficiency which is demonstrated by in vivo proton magnetic resonance spectroscopy. Measurement of guanidinoacetate in body fluids may discriminate GAMT (high concentration), AGAT (low concentration) and CRTR (normal concentration). Further biochemical characteristics include changes in creatine and creatinine concentrations in body fluids. GAMT and AGAT deficiency are treatable by oral creatine supplementation, while patients with CRTR deficiency do not respond to this type of treatment. Further recognition of patients will be of major importance for the estimation of the frequency, for the understanding of phenotypic variations and for treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenhaff, P. L., Casey, A., Short, A. H., Harris, R., Soderlund, K., & Hultman, E. (1993) · Clinical Science · doi:10.1042/cs0840565 · Cited by 460 · cited 1×
“The dose level of 350mg/kg bw per day is about 20 times the daily creatine requirement and has been reported not to induce side-effects in healthy volunteers (Greenhaff et al 1993).”
BackgroundCreatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Ipsiroglu, O. S., Stromberger, C., Ilas, J., Höger, H., Mühl, A., & Stöckler-Ipsiroglu, S. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01268-1 · Cited by 122
Self-citationGuanidinoacetate methyltransferase deficiency: New clinical features
Ganesan, V., Johnson, A., Connelly, A., Eckhardt, S., & Surtees, R. A. H. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00083-0 · Cited by 108
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Creatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Synthesis and transport of creatine in the CNS: Importance for cerebral functions
Béard, E., & Braissant, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06935.x · Cited by 192
X‐linked creatine transporter defect: An overview
Salomons, G. S., Van Dooren, S. J. M., Verhoeven, N. M., Marsden, D., Schwartz, C., Cecil, K. M., DeGrauw, T. J., & Jakobs, C. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024405821638 · Cited by 174
“The ¢rst inborn error of creatine biosynthesis was identi¢ed as a result of GAMT de¢ciency (McKusick 601240, Schulze et al 1997; St˛ckler et al 1996a,b; Stromberger et al 2003; van der Knaap et al 1999).”
BackgroundBalestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
Guanidinoacetic acid as a performance-enhancing agent
Ostojic, S. M. (2016) · Amino Acids · doi:10.1007/s00726-015-2106-y · Cited by 71
“In addition, recent neurological research reported accumulation of GAA in body fluids of children with inborn errors of creatine metabolism (Stromberger et al. 2003), suggesting that extra GAA might contribute to neurological complications.”
BackgroundBiochemical and clinical characteristics of creatine deficiency syndromes
Sykut-Cegielska, J., Gradowska, W., Mercimek-Mahmutoglu, S., & Stöckler-Ipsiroglu, S. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3520 · Cited by 60
Self-citationVerbruggen, K. T., Knijff, W. A., Soorani-Lunsing, R. J., Sijens, P. E., Verhoeven, N. M., Salomons, G. S., Goorhuis-Brouwer, S. M., & van Spronsen, F. J. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-006-0340-8 · Cited by 17
Variability of Creatine Metabolism Genes in Children with Autism Spectrum Disorder
Cameron, J. M., Levandovskiy, V., Roberts, W., Anagnostou, E., Scherer, S., Loh, A., & Schulze, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081665 · Cited by 15
“CDS includes three separate deficiencies: arginine:glycine amidinotransferase (AGAT), guanidinoacetate methyltransferase (GAMT), and creatine transporter (CrT) [4,8,19].”
Background
Metadata
- Authors
- Stromberger, C., Bodamer, O. A., & Stöckler‐Ipsiroglu, S.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2003-03
- Volume
- 26
- Issue
- 2-3
- Pages
- 299-308
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1580554837
- Cited by
- 130
- References
- 5
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.